In their debut trading on Friday, January 8 Gracell Biotechnologies, Inc. (GRCL) increased by 31.89% and closed at $25.06 per share. Shortly before the company had placed its shares in an IPO priced $19 per share.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей